Predictors of outcome of pleurodesis in patients with malignant pleural effusion: a systematic review and meta-analysis

References

• Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax. 2010 Aug 1;65(Suppl 2):ii32–40.
   PubMed Web of Science ®Google Scholar
• Mercer RM, Hassan M, Rahman NM. The role of pleurodesis in respiratory diseases. Expert Rev Respir Med. 2018 Apr;12(4):323–334.
   PubMed Web of Science ®Google Scholar
• Clive AO, Jones HE, Bhatnagar R, et al. Interventions for the management of malignant pleural effusions: a network meta-analysis. In: The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 2016. DOI:10.1002/14651858.CD010529.pub2
   Google Scholar
• Goodman A, Davies CWH. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer Amst Neth. 2006 Oct;54(1):51–55.
   PubMed Web of Science ®Google Scholar
• Rahman NM, Pepperell J, Rehal S, et al. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: the TIME1 randomized clinical trial. JAMA. 2015 Dec 22;314(24):2641–2653.
   PubMed Web of Science ®Google Scholar
• Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure. Chest. 2000 Jan;117(1):87–95.
   PubMed Web of Science ®Google Scholar
• Bielsa S, Hernández P, Rodriguez-Panadero F, et al. Tumor type influences the effectiveness of pleurodesis in malignant effusions. Lung. 2011 Apr;189(2):151–155.
   PubMed Web of Science ®Google Scholar
• Psallidas I, Kanellakis NI, Gerry S, et al. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis. Lancet Oncol. 2018 Jul;19(7):930–939.
   PubMed Web of Science ®Google Scholar
• Ferreiro L, San José E, Gude F, et al. Pleural fluid analysis and pleural elastance as predictors of response to pleurodesis in patients with malignant pleural effusion. Arch Bronconeumol Engl Ed. 2018 Mar;54(3):163–165.
   PubMed Web of Science ®Google Scholar
• Corcoran JP, Hallifax RJ, Mercer RM, et al. Thoracic ultrasound as an early predictor of pleurodesis success in malignant pleural effusion. Chest [Internet]. 2018 Sep [cited 2018 Sep 30]. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0012369218322475
   Web of Science ®Google Scholar
• Liberati A. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: explanation and Elaboration. Ann Intern Med. 2009 Aug 18;151(4):W.
   Web of Science ®Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan—a web and mobile app for systematic reviews. Syst Rev [Internet]. 2016 Dec [cited 2019 Jan 29];5(1). Available from: http://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-016-0384-4
   PubMedGoogle Scholar
• Bero L, Chartres N, Diong J, et al. The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures. Syst Rev [Internet]. 2018 Dec [cited 2019 Sep 1];7(1). Available from: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-018-0915-2
   PubMedGoogle Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005 Apr;20(5):13.
   Google Scholar
• Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Repr. Chichester: Wiley-Blackwell; 2012. p. 649. (Cochrane book series).
   Google Scholar
• Sanchez-Armengol A, Rodriguez-Panadero F. Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Chest. 1993 Nov;104(5):1482–1485.
   PubMed Web of Science ®Google Scholar
• Kennedy L, Rusch VW, Strange C, et al. Pleurodesis using talc slurry. Chest. 1994 Aug;106(2):342–346.
   PubMed Web of Science ®Google Scholar
• Viallat JR, Rey F, Astoul P, et al. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest. 1996 Dec;110(6):1387–1393.
   PubMed Web of Science ®Google Scholar
• Antony VB, Nasreen N, Mohammed KA, et al. Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis. Chest. 2004 Nov;126(5):1522–1528.
   PubMed Web of Science ®Google Scholar
• Trotter D, Aly A, Siu L, et al. Video-Assisted Thoracoscopic (VATS) pleurodesis for malignant effusion: an Australian Teaching Hospital’s experience. Heart Lung Circ. 2005 Jun;14(2):93–97.
   PubMedGoogle Scholar
• Kolschmann S, Ballin A, Gillissen A. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions. Chest. 2005 Sep;128(3):1431–1435.
   PubMed Web of Science ®Google Scholar
• Psathakis K, Calderón-Osuna E, Romero-Romero B, et al. The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis. Eur Respir J. 2006 Apr;27(4):817–821.
   PubMed Web of Science ®Google Scholar
• Debeljak A, Kecelj P, Triller N, et al. Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions. J BUON Off J Balk Union Oncol. 2006 Dec;11(4):463–467.
   PubMedGoogle Scholar
• Bilgin M, Hasdiraz L, Ozkaya M, et al. Can serum inflammatory parameters estimate outcome of pleurodesis in mesothelioma? ANZ J Surg. 2007 Apr;77(4):253–255.
   PubMed Web of Science ®Google Scholar
• Burgers JA, Kunst PWA, Koolen MGJ, et al. Pleural drainage and pleurodesis: implementation of guidelines in four hospitals. Eur Respir J. 2008 Nov 1;32(5):1321–1327.
   PubMed Web of Science ®Google Scholar
• Ak G, Metintaş M, Yildirim H, et al. Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients. Tuberk Ve Toraks. 2009;57(1):22–31.
   PubMedGoogle Scholar
• Aydogmus U, Ozdemir S, Cansever L, et al. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success. Ann Surg Oncol. 2009 Mar;16(3):745–750.
   PubMed Web of Science ®Google Scholar
• Barbetakis N, Asteriou C, Papadopoulou F, et al. Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases. J Cardiothorac Surg. 2010 Apr 19;5:27.
   PubMed Web of Science ®Google Scholar
• Nikbakhsh N, Pourhasan Amiri A, Hoseinzadeh D. Bleomycin in the treatment of 50 cases with malignant pleural effusion. Casp J Intern Med. 2011;2(3):274–278.
   PubMedGoogle Scholar
• Firoozbakhsh S, Seifirad S, Safavi E, et al. Feasibility of chemical pleurodesis with small bore catheter in patients with symptomatic malignant pleural effusions. Turk Thorac JournalTurk Toraks Derg. 2012 Mar 1;13(4):18–22.
   Google Scholar
• Fysh ETH, Tan SK, Read CA, et al. Pleurodesis outcome in malignant pleural mesothelioma: table 1. Thorax. 2013 Jun;68(6):594–596.
   PubMed Web of Science ®Google Scholar
• Wajda A, Engström H, Persson HL. Medical talc pleurodesis: which patient with cancer benefits least? J Palliat Med. 2014 Jul;17(7):822–828.
   PubMed Web of Science ®Google Scholar
• Pantazopoulos I, Xanthos T, Vlachos I, et al. Pleural fluid glucose: A predictor of unsuccessful pleurodesis in a preselected cohort of patients with malignant pleural effusion. J BUON Off J Balk Union Oncol. 2014 Dec;19(4):1018–1023.
   PubMed Web of Science ®Google Scholar
• Alsayed S, Marzouk S, Abelhalim S, et al. Malignant pleural effusion biomarkers as predictor for chemical pleurodesis success. Egypt J Chest Dis Tuberc. 2015 Jan;64(1):153–160.
   Web of Science ®Google Scholar
• Rena O, Boldorini R, Papalia E, et al. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma. Ann Thorac Surg. 2015 Apr;99(4):1177–1183.
   PubMed Web of Science ®Google Scholar
• Habal P, Omran N, Jankovicova K, et al. Predictive value of systemic and local inflammation parameters in talc pleurodesis assessment. Biomed Pap Med Fac Univ Palacky Olomouc Czechoslov. 2015 Jun;159(2):234–241.
   PubMed Web of Science ®Google Scholar
• Shehata SM, Sileem AE, El-Fakharany KM. Pleural fluid CRP, LDH, and pH as predictors of successful pleurodesis in malignant pleural effusions. Egypt J Chest Dis Tuberc. 2015 Jul;64(3):593–599.
   Web of Science ®Google Scholar
• Nohara K, Takada K, Kojima E, et al. A propensity score-matched comparison of the efficacies of OK-432 and talc slurry for pleurodesis for malignant pleural effusion induced by lung adenocarcinoma. Respir Investig. 2016 Sep;54(5):341–346.
   PubMed Web of Science ®Google Scholar
• Aktürk Ü, Koçak N, Öztürk C, et al. Small-bore versus large-bore catheters for talc pleurodesis of malignant pleural effusion: a tertiary hospital experience. Biomed Res. 2017;28(18):8001–8006.
   Google Scholar
• Arellano-Orden E, Romero-Romero B, Sánchez-López V, et al. Survivin is a negative prognostic factor in malignant pleural effusion. Eur J Clin Invest. 2018 Apr;48(4):e12895.
   Web of Science ®Google Scholar
• Mendes MA, China Pereira N, Ribeiro C, et al. Conventional versus pigtail chest tube—are they similar for treatment of malignant pleural effusions? Support Care Cancer. 2018 Aug;26(8):2499–2502.
   PubMed Web of Science ®Google Scholar
• Leemans J, Dooms C, Ninane V, et al. Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience: pleurodesis in malignant pleurisy. Respirology. 2018 Jun;23(6):613–617.
   PubMed Web of Science ®Google Scholar
• Keeratichananont W, Limthon T, Keeratichananont S. Efficacy and safety profile of autologous blood versus tetracycline pleurodesis for malignant pleural effusion. Ther Adv Respir Dis. 2015 Apr;9(2):42–48.
   PubMed Web of Science ®Google Scholar
• Hassan M, Asciak R, Mercer RM, et al. Echogenic swirling seen on ultrasound and outcome of pleurodesis in malignant pleural effusion. Arch Bronconeumol. 2019;55(12):659–661.
   PubMed Web of Science ®Google Scholar
• Hassan M, Mercer RM, Maskell NA, et al. Survival in patients with malignant pleural effusion undergoing talc pleurodesis. Lung Cancer. 2019 Sep;4(137):14–18.
   Google Scholar
• Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest. 2000 Jan;117(1):79–86.
   PubMed Web of Science ®Google Scholar
• Mercer RM, Macready J, Jeffries H, et al. Clinically important associations of pleurodesis success in malignant pleural effusion: analysis of the TIME1 data set. Respirology [Internet]. 2019 Dec 17 [cited 2019 Dec 19]. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/resp.13755
   PubMed Web of Science ®Google Scholar
• Thethi I, Ramirez S, Shen W, et al. Effect of chest tube size on pleurodesis efficacy in malignant pleural effusion: a meta-analysis of randomized controlled trials. J Thorac Dis. 2018 Jan;10(1):355–362.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Satoh H, Hasegawa S, et al. Urokinase-type plasminogen activator in carcinomatous pleural fluid. Eur Respir J. 1997 Jul 1;10(7):1566–1571.
   PubMed Web of Science ®Google Scholar
• Bhatnagar R, Keenan EK, Morley AJ, et al. Outpatient talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med. 2018 Apr 5;378(14):1313–1322.
   PubMed Web of Science ®Google Scholar